Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 248

1.

Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centres.

Sader HS, Mendes RE, Pfaller MA, Flamm RK.

J Antimicrob Chemother. 2019 Feb 7. doi: 10.1093/jac/dkz006. [Epub ahead of print]

PMID:
30753485
2.

In Vitro Activity of Tedizolid in Comparison with Other Oral and Intravenous Agents Against a Collection of Community-Acquired Methicillin-Resistant Staphylococcus aureus (2014-2015) in the United States.

Pfaller MA, Sader HS, Rhomberg PR, Flamm RK, Mendes RE.

Microb Drug Resist. 2019 Jan 29. doi: 10.1089/mdr.2018.0410. [Epub ahead of print]

PMID:
30694735
3.

Low prevalence of Gram-positive isolates showing elevated lefamulin MIC results during the surveillance program for 2015-2016 and characterization of resistance mechanisms.

Mendes RE, Paukner S, Doyle TB, Gelone SP, Flamm RK, Sader HS.

Antimicrob Agents Chemother. 2019 Jan 22. pii: AAC.02158-18. doi: 10.1128/AAC.02158-18. [Epub ahead of print]

PMID:
30670418
4.

In vitro activity of Plazomicin against Enterobacteriaceae isolates carrying genes encoding aminoglycoside-modifying enzymes most common in US Census divisions.

Castanheira M, Davis AP, Serio AW, Krause KM, Mendes RE.

Diagn Microbiol Infect Dis. 2018 Dec 5. pii: S0732-8893(18)30316-X. doi: 10.1016/j.diagmicrobio.2018.10.023. [Epub ahead of print]

PMID:
30661726
5.

Disturbance of energetic homeostasis and oxidative damage provoked by trichlorfon as relevant toxicological mechanisms using silver catfish as experimental model.

Baldissera MD, Souza CF, Descovi SN, Zanella R, Prestes OD, de Matos AFIM, da Silva AS, Baldisserotto B, Gris A, Mendes RE.

Chem Biol Interact. 2019 Feb 1;299:94-100. doi: 10.1016/j.cbi.2018.11.015. Epub 2018 Nov 24.

PMID:
30481498
6.

In vitro activity of telavancin against Staphylococcus aureus causing pneumonia or skin and skin structure infections with concomitant bloodstream infections in United States hospitals (2012-2016).

Duncan LR, Flamm RK, Sader HS, Mendes RE.

Diagn Microbiol Infect Dis. 2019 Feb;93(2):167-170. doi: 10.1016/j.diagmicrobio.2018.09.011. Epub 2018 Oct 2.

7.

Involvement of the phosphoryl transfer network on cardiac energetic metabolism during Staphylococcus aureus infection and its association to disease pathophysiology.

Perin G, Baldissera MD, Jaguezeski AM, Crecencio RB, Stefani LM, Gris A, Mendes RE, Souza CF, Dalzuk V, da Silva AS.

Microb Pathog. 2019 Jan;126:318-322. doi: 10.1016/j.micpath.2018.11.011. Epub 2018 Nov 12.

PMID:
30439401
8.

Aminoglycoside-Modifying Enzymes and 16S Ribosomal RNA Methyltransferases-Encoding Genes Among a Global Collection of Gram-Negative Isolates.

Costello SE, Deshpande LM, Davis AP, Mendes RE, Castanheira M.

J Glob Antimicrob Resist. 2018 Oct 30. pii: S2213-7165(18)30209-1. doi: 10.1016/j.jgar.2018.10.020. [Epub ahead of print]

PMID:
30389638
9.

Ceftobiprole Activity against Gram-Positive and -Negative Pathogens Collected from the United States in 2006 and 2016.

Pfaller MA, Flamm RK, Mendes RE, Streit JM, Smart JI, Hamed KA, Duncan LR, Sader HS.

Antimicrob Agents Chemother. 2018 Dec 21;63(1). pii: e01566-18. doi: 10.1128/AAC.01566-18. Print 2019 Jan.

PMID:
30373807
10.

Effects of supplying omega-3 polyunsaturated fatty acids to gilts after weaning on metabolism and ovarian gene expression.

Otte MV, Moreira F, Bianchi I, Oliveira J Jr, Mendes RE, Haas CS, Anciuti AN, Rovani MT, Gasperin BG, Lucia T Jr.

J Anim Sci. 2019 Jan 1;97(1):374-384. doi: 10.1093/jas/sky419.

PMID:
30371788
11.

Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America.

Sader HS, Flamm RK, Streit JM, Carvalhaes CG, Mendes RE.

Int J Infect Dis. 2018 Dec;77:82-86. doi: 10.1016/j.ijid.2018.10.004. Epub 2018 Oct 10.

12.

In vitro activity of tedizolid against clinical isolates of Staphylococcus lugdunensis and Staphylococcus haemolyticus from Europe and the United States.

Farrell DJ, Mendes RE, Bensaci M.

Diagn Microbiol Infect Dis. 2019 Jan;93(1):85-88. doi: 10.1016/j.diagmicrobio.2018.08.006. Epub 2018 Aug 23.

PMID:
30314652
13.

Spray-dried porcine plasma added to diets contaminated with aflatoxins and fumonisins shows beneficial effects to piglet health.

Müller LKF, Paiano D, Bottari NB, Santurio JM, Zampar A, Schetinger MRC, Zanette RA, Mendes RE, Gloria EM, Baldissera MD, Silva ASD.

An Acad Bras Cienc. 2018 Jul-Sep;90(3):3115-3128. doi: 10.1590/0001-3765201820170794.

14.

Evaluation of the Revised Ceftaroline Disk Diffusion Breakpoints When Testing a Challenge Collection of Methicillin-Resistant Staphylococcus aureus Isolates.

Sader HS, Rhomberg PR, Doyle TB, Flamm RK, Mendes RE.

J Clin Microbiol. 2018 Nov 27;56(12). pii: e00777-18. doi: 10.1128/JCM.00777-18. Print 2018 Dec.

15.

PEGylated meloxicam-loaded nanocapsules reverse in vitro damage on caspase activity and do not induce toxicity in cultured human lymphocytes and mice.

Nishihira VSK, Fontana BD, Ianiski FR, de Almeida HS, Posser CP, Dias JB, Parodi CB, Piva MM, Gris A, Mendes RE, Duarte MMMF, Sagrillo MR, Luchese C, Rech VC, Vaucher RA.

Biomed Pharmacother. 2018 Nov;107:1259-1267. doi: 10.1016/j.biopha.2018.08.120. Epub 2018 Aug 30.

PMID:
30257340
16.

Effects of phytogenic feed additive based on thymol, carvacrol and cinnamic aldehyde on body weight, blood parameters and environmental bacteria in broilers chickens.

Reis JH, Gebert RR, Barreta M, Baldissera MD, Dos Santos ID, Wagner R, Campigotto G, Jaguezeski AM, Gris A, de Lima JLF, Mendes RE, Fracasso M, Boiago MM, Stefani LM, Dos Santos DS, Robazza WS, Da Silva AS.

Microb Pathog. 2018 Dec;125:168-176. doi: 10.1016/j.micpath.2018.09.015. Epub 2018 Sep 8.

PMID:
30205193
17.

Listeria monocytogenes impairs enzymes of the phosphotransfer network and alters antioxidant/oxidant status in cattle brain structures.

Jaguezeski AM, Baldissera MD, Rhoden LA, Gomes TMA, Mendes RE, Bottari NB, Morsch VM, Schetinger MRC, Stefani LM, Giongo JL, Vaucher RA, Da Silva AS.

Microb Pathog. 2018 Nov;124:284-290. doi: 10.1016/j.micpath.2018.08.044. Epub 2018 Aug 22.

PMID:
30142467
18.

Frequency and antimicrobial susceptibility of Gram-negative bacteria isolated from patients with pneumonia hospitalized in ICUs of US medical centres (2015-17).

Sader HS, Castanheira M, Mendes RE, Flamm RK.

J Antimicrob Chemother. 2018 Nov 1;73(11):3053-3059. doi: 10.1093/jac/dky279.

PMID:
30060117
19.

Activity of dalbavancin and comparator agents against Gram-positive cocci from clinical infections in the USA and Europe 2015-16.

Pfaller MA, Mendes RE, Duncan LR, Flamm RK, Sader HS.

J Antimicrob Chemother. 2018 Oct 1;73(10):2748-2756. doi: 10.1093/jac/dky235.

PMID:
29982565
20.

Evolving oxazolidinone resistance mechanisms in a worldwide collection of enterococcal clinical isolates: results from the SENTRY Antimicrobial Surveillance Program.

Deshpande LM, Castanheira M, Flamm RK, Mendes RE.

J Antimicrob Chemother. 2018 Sep 1;73(9):2314-2322. doi: 10.1093/jac/dky188.

PMID:
29878213
21.

In Vitro Activity of Plazomicin against Gram-Negative and Gram-Positive Isolates Collected from U.S. Hospitals and Comparative Activities of Aminoglycosides against Carbapenem-Resistant Enterobacteriaceae and Isolates Carrying Carbapenemase Genes.

Castanheira M, Davis AP, Mendes RE, Serio AW, Krause KM, Flamm RK.

Antimicrob Agents Chemother. 2018 Jul 27;62(8). pii: e00313-18. doi: 10.1128/AAC.00313-18. Print 2018 Aug.

22.

Experimental infection of cattle with Listeria monocytogenes: Participation of purinergic metabolism in disease pathogenesis.

Jaguezeski AM, Perin G, Rhoden LA, da Silva TMA, Mendes RE, Bottari NB, Faccin T, Baldissera MD, Morsch VM, Schetinger MRC, Giongo JL, da Silva AS.

Microb Pathog. 2018 Sep;122:25-29. doi: 10.1016/j.micpath.2018.05.054. Epub 2018 May 30.

PMID:
29859295
23.

Production, characterization and toxicology assay of creatine pegylated nanoliposome with polysorbate 80 for brain delivery.

Borin DB, Mezzomo NJ, Vaucher RA, Carmo GD, Rodrigues Junior LC, Sulczewski FB, Schwertz CI, Mendes RE, Damiani AP, Andrade VM, Rech VC, Boeck CR.

An Acad Bras Cienc. 2018 Aug;90(2 suppl 1):2317-2329. doi: 10.1590/0001-3765201820170553. Epub 2018 Apr 23.

24.

ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries.

Mendes RE, Deshpande L, Streit JM, Sader HS, Castanheira M, Hogan PA, Flamm RK.

J Antimicrob Chemother. 2018 Jul 1;73(7):1880-1887. doi: 10.1093/jac/dky099.

PMID:
29659858
25.

Molecular β-lactamase characterization of Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials (RECAPTURE 1 and 2) for complicated urinary tract infections: Efficacies analysed against susceptible and resistant subsets.

Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK.

Int J Antimicrob Agents. 2018 Aug;52(2):287-292. doi: 10.1016/j.ijantimicag.2018.04.001. Epub 2018 Apr 11.

PMID:
29654893
26.

Oritavancin in vitro activity against gram-positive organisms from European and United States medical centers: results from the SENTRY Antimicrobial Surveillance Program for 2010-2014.

Pfaller MA, Sader HS, Flamm RK, Castanheira M, Mendes RE.

Diagn Microbiol Infect Dis. 2018 Jun;91(2):199-204. doi: 10.1016/j.diagmicrobio.2018.01.029. Epub 2018 Feb 3.

PMID:
29567128
27.

In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.

Pfaller MA, Huband MD, Mendes RE, Flamm RK, Castanheira M.

Int J Antimicrob Agents. 2018 Aug;52(2):144-150. doi: 10.1016/j.ijantimicag.2018.02.021. Epub 2018 Mar 3.

PMID:
29510189
28.

Ecto-enzymes activities in splenic lymphocytes of mice experimentally infected by Trypanosoma cruzi and treated with specific avian immunoglobulins: an attempt to improve the immune response.

Grando TH, Baldissera MD, Do Carmo G, Oliveira CB, Santi ET, Doleski PH, Leal DBR, Stefani LM, Mendes RE, Da Silva AS, Monteiro SG.

Mol Cell Biochem. 2018 Nov;448(1-2):9-15. doi: 10.1007/s11010-018-3308-x. Epub 2018 Feb 12.

PMID:
29435869
29.

Nucleotide and nucleoside involvement in immunomodulation in experimental Chagas disease.

do Carmo GM, de Sá MF, Baldissera MD, Grando TH, Mendes RE, Cardoso VV, Casali EA, Moritz CEJ, Monteiro SG, Da Silva AS.

Mol Cell Biochem. 2018 Oct;447(1-2):203-208. doi: 10.1007/s11010-018-3304-1. Epub 2018 Feb 5.

PMID:
29404886
30.

Antimicrobial activity of oritavancin and comparator agents when tested against Gram-positive bacterial isolates causing infections in cancer patients (2014-16).

Pfaller MA, Sader HS, Castanheira M, Flamm RK, Mendes RE.

J Antimicrob Chemother. 2018 Apr 1;73(4):916-922. doi: 10.1093/jac/dkx485.

PMID:
29294031
31.

Dalbavancin in-vitro activity obtained against Gram-positive clinical isolates causing bone and joint infections in US and European hospitals (2011-2016).

Pfaller MA, Flamm RK, Castanheira M, Sader HS, Mendes RE.

Int J Antimicrob Agents. 2018 Apr;51(4):608-611. doi: 10.1016/j.ijantimicag.2017.12.011. Epub 2017 Dec 23.

PMID:
29277526
32.

Antimicrobial Activity of Dalbavancin against Staphylococcus aureus with Decreased Susceptibility to Glycopeptides, Daptomycin, and/or Linezolid from U.S. Medical Centers.

Sader HS, Mendes RE, Duncan LR, Pfaller MA, Flamm RK.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02397-17. doi: 10.1128/AAC.02397-17. Print 2018 Mar.

33.

Activity of Ceftolozane-Tazobactam against Pseudomonas aeruginosa and Enterobacteriaceae Isolates Collected from Respiratory Tract Specimens of Hospitalized Patients in the United States during 2013 to 2015.

Castanheira M, Duncan LR, Mendes RE, Sader HS, Shortridge D.

Antimicrob Agents Chemother. 2018 Feb 23;62(3). pii: e02125-17. doi: 10.1128/AAC.02125-17. Print 2018 Mar.

34.

In Vitro Activities of Ceftaroline and Comparators against Streptococcus pneumoniae Isolates from U.S. Hospitals: Results from Seven Years of the AWARE Surveillance Program (2010 to 2016).

Pfaller MA, Mendes RE, Duncan LR, Flamm RK, Sader HS.

Antimicrob Agents Chemother. 2018 Jan 25;62(2). pii: e01555-17. doi: 10.1128/AAC.01555-17. Print 2018 Feb.

35.

Changes on the activity of cholinesterase's in an immunomodulatory response of cattle infected by Listeria monocytogenes.

Jaguezeski AM, Perin G, Rhoden LA, da Silva TMA, Mendes RE, Bottari NB, Baldissera MD, Morsch VM, Schetinger MRC, Stefani LM, da Silva AS.

Microb Pathog. 2018 Jan;114:36-40. doi: 10.1016/j.micpath.2017.10.038. Epub 2017 Oct 21.

PMID:
29066379
36.

Antimicrobial Activities of Aztreonam-Avibactam and Comparator Agents against Contemporary (2016) Clinical Enterobacteriaceae Isolates.

Sader HS, Mendes RE, Pfaller MA, Shortridge D, Flamm RK, Castanheira M.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01856-17. doi: 10.1128/AAC.01856-17. Print 2018 Jan.

37.

Treatment with 3'-deoxyadenosine and deoxycoformycin in mice infected by Trypanosoma cruzi and its side effect on purinergic enzymes.

do Carmo GM, Doleski PH, de Sá MF, Grando TH, Azevedo MI, Manzoni AG, Leal DBR, Gressler LT, Henker LC, Mendes RE, Baldissera MD, Monteiro SG, Stefani LM, Da Silva AS.

Microb Pathog. 2017 Dec;113:51-56. doi: 10.1016/j.micpath.2017.10.030. Epub 2017 Oct 17.

PMID:
29051060
38.

ZAAPS Program results for 2015: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 32 countries.

Pfaller MA, Mendes RE, Streit JM, Hogan PA, Flamm RK.

J Antimicrob Chemother. 2017 Nov 1;72(11):3093-3099. doi: 10.1093/jac/dkx251.

PMID:
28961701
39.

Antimicrobial Activity of Ceftazidime-Avibactam Tested against Multidrug-Resistant Enterobacteriaceae and Pseudomonas aeruginosa Isolates from U.S. Medical Centers, 2013 to 2016.

Sader HS, Castanheira M, Shortridge D, Mendes RE, Flamm RK.

Antimicrob Agents Chemother. 2017 Oct 24;61(11). pii: e01045-17. doi: 10.1128/AAC.01045-17. Print 2017 Nov.

40.

Relation between acetylcholinesterase and Na+, K+-ATPase activities with impaired memory of mice experimentally infected by Trypanosoma cruzi.

Baldissera MD, Souza CF, Carmo GM, Monteiro SG, Mendes RE, Stefani LM, da Silva AS.

Microb Pathog. 2017 Oct;111:75-80. doi: 10.1016/j.micpath.2017.08.019. Epub 2017 Aug 18.

PMID:
28823791
41.

Diphenyl diselenide modulates nucleotidases, reducing inflammatory responses in the liver of Toxoplasma gondii-infected mice.

Doleski PH, Leal DBR, Machado VS, Bottari NB, Manzoni AG, Casali EA, Moritz CEJ, Rocha ACA, Camillo G, Vogel FF, Stefani LM, Mendes RE, da Silva AS.

Purinergic Signal. 2017 Dec;13(4):489-496. doi: 10.1007/s11302-017-9575-2. Epub 2017 Aug 16.

42.

Chagas disease: modulation of the inflammatory response by acetylcholinesterase in hematological cells and brain tissue.

Silva AD, Bottari NB, do Carmo GM, Baldissera MD, Souza CF, Machado VS, Morsch VM, Schetinger MRC, Mendes RE, Monteiro SG, Da Silva AS.

Mol Cell Biochem. 2018 Jan;438(1-2):59-65. doi: 10.1007/s11010-017-3113-y. Epub 2017 Aug 1.

PMID:
28766165
43.

Relationship between day 1 and day 2 Vancomycin area under the curve values and emergence of heterogeneous Vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest® macromethod among patients with MRSA bloodstream infections: a pilot study.

Martirosov DM, Bidell MR, Pai MP, Scheetz MH, Rosenkranz SL, Faragon C, Malik M, Mendes RE, Jones RN, McNutt LA, Lodise TP.

BMC Infect Dis. 2017 Aug 2;17(1):534. doi: 10.1186/s12879-017-2609-0.

44.

Activity of dalbavancin tested against Gram-positive clinical isolates causing skin and skin-structure infections in paediatric patients from US hospitals (2014-2015).

Pfaller MA, Mendes RE, Sader HS, Castanheira M, Flamm RK.

J Glob Antimicrob Resist. 2017 Dec;11:4-7. doi: 10.1016/j.jgar.2017.06.003. Epub 2017 Jul 19.

PMID:
28735053
45.

Telavancin activity in vitro tested against a worldwide collection of Gram-positive clinical isolates (2014).

Duncan LR, Sader HS, Smart JI, Flamm RK, Mendes RE.

J Glob Antimicrob Resist. 2017 Sep;10:271-276. doi: 10.1016/j.jgar.2017.03.018. Epub 2017 Jul 19.

PMID:
28735051
46.

In Vitro Activity of Telavancin Against Clinically Important Gram-Positive Pathogens from 69 U.S. Medical Centers (2015): Potency Analysis by U.S. Census Divisions.

Pfaller MA, Sader HS, Flamm RK, Castanheira M, Smart JI, Mendes RE.

Microb Drug Resist. 2017 Sep;23(6):718-726. doi: 10.1089/mdr.2017.0022. Epub 2017 Jul 20.

47.

Toxoplasmosis treatment with diphenyl diselenide in infected mice modulates the activity of purinergic enzymes and reduces inflammation in spleen.

Doleski PH, Ten Caten MV, Passos DF, Castilhos LG, Leal DBR, Machado VS, Bottari NB, Vogel FF, Mendes RE, da Silva AS.

Exp Parasitol. 2017 Oct;181:7-13. doi: 10.1016/j.exppara.2017.07.001. Epub 2017 Jul 12.

PMID:
28710007
48.

Risk factors for Neospora caninum infection in dairy cattle and their possible cause-effect relation for disease.

Fávero JF, Da Silva AS, Campigotto G, Machado G, Daniel de Barros L, Garcia JL, Vogel FF, Mendes RE, Stefani LM.

Microb Pathog. 2017 Sep;110:202-207. doi: 10.1016/j.micpath.2017.06.042. Epub 2017 Jun 27.

PMID:
28666842
49.
50.

Antimicrobial Susceptibility Trends among Staphylococcus aureus Isolates from U.S. Hospitals: Results from 7 Years of the Ceftaroline (AWARE) Surveillance Program, 2010 to 2016.

Sader HS, Mendes RE, Streit JM, Flamm RK.

Antimicrob Agents Chemother. 2017 Aug 24;61(9). pii: e01043-17. doi: 10.1128/AAC.01043-17. Print 2017 Sep.

Supplemental Content

Loading ...
Support Center